Oligosaccharide for Infant Formula Market Report – Research, Industry Analysis Reports and Market Demands

Global Oligosaccharide for Infant Formula Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope of Oligosaccharide for Infant Formula
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Oligosaccharide for Infant Formula Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Fructooligosaccharide
- 1.3.3 Galactooligosaccharides
- 1.3.4 Human Milk Oligosaccharides
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Oligosaccharide for Infant Formula Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Standard
- 1.4.3 Follow on
- 1.4.4 Toddler
- 1.4.5 Specialty
1.5 Global Oligosaccharide for Infant Formula Market Size & Forecast
- 1.5.1 Global Oligosaccharide for Infant Formula Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Oligosaccharide for Infant Formula Sales Quantity (2018-2029)
- 1.5.3 Global Oligosaccharide for Infant Formula Average Price (2018-2029)

2 Manufacturers Profiles

3 Competitive Environment: Oligosaccharide for Infant Formula by Manufacturer

3.1 Global Oligosaccharide for Infant Formula Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oligosaccharide for Infant Formula Revenue by Manufacturer (2018-2023)
3.3 Global Oligosaccharide for Infant Formula Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Oligosaccharide for Infant Formula by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Oligosaccharide for Infant Formula Manufacturer Market Share in 2022
- 3.4.2 Top 6 Oligosaccharide for Infant Formula Manufacturer Market Share in 2022
3.5 Oligosaccharide for Infant Formula Market: Overall Company Footprint Analysis
- 3.5.1 Oligosaccharide for Infant Formula Market: Region Footprint
- 3.5.2 Oligosaccharide for Infant Formula Market: Company Product Type Footprint
- 3.5.3 Oligosaccharide for Infant Formula Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Oligosaccharide for Infant Formula Market Size by Region
- 4.1.1 Global Oligosaccharide for Infant Formula Sales Quantity by Region (2018-2029)
- 4.1.2 Global Oligosaccharide for Infant Formula Consumption Value by Region (2018-2029)
- 4.1.3 Global Oligosaccharide for Infant Formula Average Price by Region (2018-2029)
4.2 North America Oligosaccharide for Infant Formula Consumption Value (2018-2029)
4.3 Europe Oligosaccharide for Infant Formula Consumption Value (2018-2029)
4.4 Asia-Pacific Oligosaccharide for Infant Formula Consumption Value (2018-2029)
4.5 South America Oligosaccharide for Infant Formula Consumption Value (2018-2029)
4.6 Middle East and Africa Oligosaccharide for Infant Formula Consumption Value (2018-2029)

5 Market Segment by Type

5.1 Global Oligosaccharide for Infant Formula Sales Quantity by Type (2018-2029)
5.2 Global Oligosaccharide for Infant Formula Consumption Value by Type (2018-2029)
5.3 Global Oligosaccharide for Infant Formula Average Price by Type (2018-2029)

6 Market Segment by Application

6.1 Global Oligosaccharide for Infant Formula Sales Quantity by Application (2018-2029)
6.2 Global Oligosaccharide for Infant Formula Consumption Value by Application (2018-2029)
6.3 Global Oligosaccharide for Infant Formula Average Price by Application (2018-2029)

7 North America

7.1 North America Oligosaccharide for Infant Formula Sales Quantity by Type (2018-2029)
7.2 North America Oligosaccharide for Infant Formula Sales Quantity by Application (2018-2029)
7.3 North America Oligosaccharide for Infant Formula Market Size by Country
- 7.3.1 North America Oligosaccharide for Infant Formula Sales Quantity by Country (2018-2029)
- 7.3.2 North America Oligosaccharide for Infant Formula Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

8.1 Europe Oligosaccharide for Infant Formula Sales Quantity by Type (2018-2029)
8.2 Europe Oligosaccharide for Infant Formula Sales Quantity by Application (2018-2029)
8.3 Europe Oligosaccharide for Infant Formula Market Size by Country
- 8.3.1 Europe Oligosaccharide for Infant Formula Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Oligosaccharide for Infant Formula Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

9.1 Asia-Pacific Oligosaccharide for Infant Formula Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oligosaccharide for Infant Formula Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oligosaccharide for Infant Formula Market Size by Region
- 9.3.1 Asia-Pacific Oligosaccharide for Infant Formula Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Oligosaccharide for Infant Formula Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

10.1 South America Oligosaccharide for Infant Formula Sales Quantity by Type (2018-2029)
10.2 South America Oligosaccharide for Infant Formula Sales Quantity by Application (2018-2029)
10.3 South America Oligosaccharide for Infant Formula Market Size by Country
- 10.3.1 South America Oligosaccharide for Infant Formula Sales Quantity by Country (2018-2029)
- 10.3.2 South America Oligosaccharide for Infant Formula Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

11.1 Middle East & Africa Oligosaccharide for Infant Formula Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oligosaccharide for Infant Formula Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oligosaccharide for Infant Formula Market Size by Country
- 11.3.1 Middle East & Africa Oligosaccharide for Infant Formula Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Oligosaccharide for Infant Formula Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

12.1 Oligosaccharide for Infant Formula Market Drivers
12.2 Oligosaccharide for Infant Formula Market Restraints
12.3 Oligosaccharide for Infant Formula Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

13.1 Raw Material of Oligosaccharide for Infant Formula and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oligosaccharide for Infant Formula
13.3 Oligosaccharide for Infant Formula Production Process
13.4 Oligosaccharide for Infant Formula Industrial Chain

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Oligosaccharide for Infant Formula Typical Distributors
14.3 Oligosaccharide for Infant Formula Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Oligosaccharide for Infant Formula market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby's gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow's milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.
The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby's gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.
Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby's immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.
It's important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.
Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby's gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow's milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.
The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby's gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.
Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby's immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.
It's important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.

Oligosaccharides for infant formula refer to a group of carbohydrates that are added to infant formula to mimic the naturally occurring oligosaccharides found in human breast milk. Oligosaccharides are composed of a small number of sugar molecules linked together, typically ranging from two to ten sugar units.
This report is a detailed and comprehensive analysis for global Oligosaccharide for Infant Formula market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oligosaccharide for Infant Formula market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Oligosaccharide for Infant Formula market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Oligosaccharide for Infant Formula market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Oligosaccharide for Infant Formula market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oligosaccharide for Infant Formula
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oligosaccharide for Infant Formula market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FrieslandCampina, Meiji, Yakult, Baolingbao and Beneo-Orafti, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oligosaccharide for Infant Formula market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fructooligosaccharide
Galactooligosaccharides
Human Milk Oligosaccharides
Market segment by Application
Standard
Follow on
Toddler
Specialty
Major players covered
FrieslandCampina
Meiji
Yakult
Baolingbao
Beneo-Orafti
Bailong
Ingredion
Sensus
QHT
Nikon Shikuhin KaKo
Nissin-sugar
Cosucra
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oligosaccharide for Infant Formula product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oligosaccharide for Infant Formula, with price, sales, revenue and global market share of Oligosaccharide for Infant Formula from 2018 to 2023.
Chapter 3, the Oligosaccharide for Infant Formula competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oligosaccharide for Infant Formula breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oligosaccharide for Infant Formula market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oligosaccharide for Infant Formula.
Chapter 14 and 15, to describe Oligosaccharide for Infant Formula sales channel, distributors, customers, research findings and conclusion.

Buy now